• Text Resize A A A
  • Print Print
  • Share Share Share Share

DCO Activity Data

Background:

Section 289 of the Public Health Service Act authorizes OHRP, on behalf of the U.S. Department of Health and Human Services (HHS), to establish a compliance oversight process regarding violations of the rights of human subjects of research conducted or supported by HHS. Pursuant to this authority, OHRP may receive reports of such violations and take appropriate action.

OHRP also derives compliance authority from the HHS regulations for the protection of human research subjects at 45 CFR part 46 (hereinafter referred to as "the HHS regulations"). HHS regulations at 45 CFR 46.103(a) require each institution engaged in non-exempt human subjects research that is conducted or supported by HHS to provide written assurance that it will comply with the requirements of the HHS regulations. On behalf of HHS, OHRP reviews and approves these written agreements, called assurances of compliance (Federalwide Assurances or FWAs). An FWA approved by OHRP commits the entire institution (including institutional officials, IRBs designated in the FWA, research investigators, and all other employees or agents) to full compliance with the HHS regulations whenever the institution is engaged in HHS-supported research.

Division of Compliance Oversight (DCO) Activity Data:

OHRP has responsibility for oversight of compliance with the HHS regulations for the protection of human research subjects (see 45 CFR Part 46). In carrying out this responsibility, DCO is the division within OHRP that reviews allegations of noncompliance involving human subject research conducted or supported by HHS or otherwise subject to HHS regulations, and determines whether to conduct a for-cause compliance evaluation. DCO also conducts a program of not-for-cause surveillance evaluations of institutions, and responds to incident reports (referred to in this document as IRPTs submitted from Federalwide Assurance holding institutions. Incident reports include: reports of unanticipated problems involving risks to subjects or others; serious or continuing noncompliance with HHS regulations at 45 CFR part 46 or the requirements or determinations of the institutional review board (IRB); and suspensions or terminations of IRB approval.

The following report includes aggregate data on several key activities performed by DCO:

2019

IRPTs 1Q Fiscal 2019 2Q Fiscal 2019
Total number of emails reviewed that have yet to be processed as of the end of the quarter 1176 N/A
Total Number of IRPTs Processed 450 N/A
Complaints 1Q Fiscal 2019 2Q Fiscal 2019
Complaints Received 5 N/A
Cases 1Q Fiscal 2019 2Q Fiscal 2019
Total Number of Active Cases 15 N/A
Cases Closed in the Quarter 0 N/A

Data for the current year up to now:

Total number of IRPT emails reviewed that have yet to be processed as of the end of the quarter
1176 emails reviewed that have yet to be processed in 1Q Fiscal 2019
Total Number of IRPTs Processed
450 IRPTs Processed in 1Q Fiscal 2019
Complaints Received
5 Complaints Received in 1Q Fiscal 2019
Cases
15 Active Cases and 0 Cases closed in 1Q Fiscal 2019

Definitions:

Incident Reports ("IRPTs") – This data represents the number of incident reports received and reviewed by OHRP.  OHRP reviews all incident reports within 48 business hours to identify incidents that require urgent action from OHRP. Incident reports include: reports of unanticipated problems involving risks to subjects or others; serious or continuing noncompliance with the HHS regulations at 45 CFR part 46 or the requirements or determinations of the IRB; and suspensions or terminations of IRB approval. For more information about incident reporting please refer to Guidance on Reporting Incident to OHRP at https://www.hhs.gov/ohrp/compliance-and-reporting/guidance-on-reporting-incident/index.html

Complaints – This data represents the number of allegations of noncompliance involving human subject research received by OHRP.  Sources of such allegations or indications of noncompliance include, but are not limited to, research subjects and their family members, individuals involved in the conduct of research such as investigators and study coordinators, institutional officials, and research publications.  OHRP may choose to use other mechanisms to address complaints of noncompliance rather than opening a for-cause evaluation.

Compliance Cases – This data represents the number of OHRP cases that are ongoing and includes both for-cause and not-for-cause cases.

For-cause evaluations occur at OHRP's discretion, in response to OHRP's receipt of substantive written allegations or indications of noncompliance with the HHS regulations.  Sources of such allegations or indications of noncompliance include, but are not limited to, research subjects and their family members, individuals involved in the conduct of research such as investigators and study coordinators, institutional officials, and research publications.

For-cause cases are those that are generally initiated as a result of allegations of non-compliance.  Sources of such allegations or indications of noncompliance include, but are not limited to, research subjects and their family members, individuals involved in the conduct of research such as investigators and study coordinators, institutional officials, and research publications.  OHRP may choose to use other mechanisms to address allegations or indications of noncompliance rather than conducting a for-cause evaluation.  In general, information about these compliance activities are not provided to the public. For further details see OHRP’s guidance, "Compliance Oversight Procedures for Evaluating Institutions".

Not-for-cause compliance oversight evaluations are conducted in the absence of substantive allegations or indications of noncompliance.  Institutions are selected for not-for-cause evaluation based on a range of considerations, including: (a) the volume of HHS-conducted or -supported research in which they are engaged; (b) whether they have a history of a relatively low level of reporting to OHRP under the requirements of HHS regulations at 45 CFR 46.103(b)(5); (c) the need to evaluate implementation of corrective actions following a previous for-cause compliance oversight evaluation; (d) geographic location; (e) status of accreditation by professionally recognized human subject protection program accreditation groups; and (f) status of recent human subject protection evaluations or audits by other regulatory agencies (such as the Food and Drug Administration).

For more information about compliances cases and how they are conducted, please visit OHRP’s website at: https://www.hhs.gov/ohrp/compliance-and-reporting/evaluating-institutions/index.html

Content created by Office for Human Research Protections (OHRP)
Content last reviewed on July 30, 2018